Losing weight with lifestyle changes in an intensive behavioral weight loss program was associated with a decrease in risk factors for cardiovascular disease and Type 2 diabetes for at least five years—even if some weight ...
Mar 28, 2023
0
29
A urothelial cancer (UC) prediction model, which considers 10 genes with the highest performance from the UroAmp urinary comprehensive genomic profiling (uCGP) test, has high sensitivity and specificity, according to a study ...
Mar 21, 2023
0
11
Your diet—the foods and drinks you eat, not short-term restrictive programs—can impact your heart disease risk. Evidence-based approaches to eating are used by dietitians and physicians to prevent and treat cardiovascular ...
Mar 20, 2023
0
3
Nearly half of parents say they would definitely know if their child was vaping, despite characteristics of vaping devices that make it easy to hide or disguise their use, a new national poll suggests.
Mar 20, 2023
0
18
Professor Sang Yup Lee's research team in KAIST's Department of Biochemical Engineering has developed an advanced AI-based drug interaction prediction technology that analyzed the interaction between Paxlovid ingredients ...
Mar 16, 2023
0
50
A new way to identify more specific, higher-risk groups of older surgical patients can help in clinical decision-making and accurately comparing the performance of one hospital to another, according to research published ...
Mar 15, 2023
0
9
Children living in the most disadvantaged communities have a 60% greater likelihood of being diagnosed with primary hypertension, the leading risk factor for developing cardiovascular disease later in life, according to the ...
Mar 15, 2023
0
30
Change is needed to the way safer sleep information is communicated, if risks to babies from unsafe sleeping practices are to be reduced, according to a new report involving UCL researchers.
Mar 13, 2023
0
4
Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, ...
Mar 10, 2023
0
1
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG ...
Mar 9, 2023
0
31
